SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-21-000194
Filing Date
2021-09-17
Accepted
2021-09-17 07:00:36
Documents
15
Period of Report
2021-09-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20210917.htm   iXBRL 8-K 45826
2 EX-99.1 exhibit991-emaqa09172021.htm EX-99.1 6354
6 GRAPHIC exhibit991-emaqa09172021001.jpg GRAPHIC 176967
7 GRAPHIC exhibit991-emaqa09172021002.jpg GRAPHIC 202365
  Complete submission text file 0001485003-21-000194.txt   721098

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20210917.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20210917_lab.xml EX-101.LAB 24993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20210917_pre.xml EX-101.PRE 13190
8 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20210917_htm.xml XML 11797
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 211259218
SIC: 2834 Pharmaceutical Preparations